Morepen Laboratories Limited

Morepen Laboratories Limited is a diversified Indian pharmaceutical and medical devices manufacturer headquartered in Baddi, Himachal Pradesh, with over 40 years of operational history. The company operates through four primary business segments: Global Generics (Active Pharmaceutical Ingredients), Home Health (home diagnostic products), Dr. Morepen (OTC and healthcare products), and Finished Formulations (generic medicines). The company manufactures and distributes home monitoring devices including blood glucose monitors, blood pressure monitors, nebulizers, thermometers, weighing scales, and steamers. It has an installed base exceeding 14 million glucometers and has sold over 450 million glucose test strips. Morepen holds USFDA approval since 1998 and maintains certifications including WHO GMP, EU GMP, ISO 9001:2005, and ISO 13485:2016 for medical devices manufacturing. The company operates 10 specialized manufacturing plants and exports to over 80 countries. Key product lines include the Dr. Morepen branded glucose monitors and strips with production capacity of 150 million strips and 1 million meters annually, blood pressure monitors, and OTC healthcare products such as Burnol (burns cream) and Lemolate (cough/cold remedy). The company also manufactures active pharmaceutical ingredients, including Montelukast (45 MT annual capacity, world's largest producer), Loratadine (120 MT capacity with over 90% US market share), and Atorvastatin. In the pharmaceutical segment, Morepen serves multispecialty, cardiac, and diabetic categories through dedicated business units with 150+ SKUs. The company has a large domestic distribution network with over 2,000 direct-billed distributors in India and service centers across all four zones.